242 related articles for article (PubMed ID: 8794418)
1. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
Bygdeman M; Swahn ML
Maturitas; 1996 Apr; 23(3):259-63. PubMed ID: 8794418
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
3. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry.
van der Laak JA; de Bie LM; de Leeuw H; de Wilde PC; Hanselaar AG
J Clin Pathol; 2002 Jun; 55(6):446-51. PubMed ID: 12037029
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
5. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
Garcia de Arriba S; Grüntkemeier L; Häuser M; May TW; Masur C; Stute P
PLoS One; 2022; 17(5):e0266633. PubMed ID: 35551533
[TBL] [Abstract][Full Text] [Related]
6. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
Stute P
Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
[TBL] [Abstract][Full Text] [Related]
7. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
[TBL] [Abstract][Full Text] [Related]
8. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
[TBL] [Abstract][Full Text] [Related]
9. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
[TBL] [Abstract][Full Text] [Related]
10. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
[TBL] [Abstract][Full Text] [Related]
11. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
12. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women.
Suwanvesh N; Manonai J; Sophonsritsuk A; Cherdshewasart W
Menopause; 2017 Feb; 24(2):210-215. PubMed ID: 27749740
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
Vale F; Rezende C; Raciclan A; Bretas T; Geber S
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618
[TBL] [Abstract][Full Text] [Related]
15. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
Stute P; May TW; Masur C; Schmidts-Winkler IM
Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
[TBL] [Abstract][Full Text] [Related]
17. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
[TBL] [Abstract][Full Text] [Related]
19. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
Chatsiproios D; Schmidts-Winkler IM; König L; Masur C; Abels C
PLoS One; 2019; 14(1):e0210967. PubMed ID: 30677065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
